[EFFECT] Calidi Biotherapeutics, Inc. SEC Filing
Filing Impact
Filing Sentiment
Form Type
EFFECT
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreiben Sie den folgenden Text um:
Positive
- None.
Negative
- None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreiben Sie den folgenden Text um:
Calidi Biotherapeutics Inc
NYSE:CLDI
CLDI Rankings
CLDI Latest News
Jul 25, 2025
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on聽August 5, 2025
Jul 22, 2025
Join Calidi Biotherapeutics鈥� Exclusive Live Investor Webinar and Q&A Session on July 24
Jul 10, 2025
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment
CLDI Latest SEC Filings
CLDI Stock Data
25.52M
34.45M
7.88%
4.06%
2.99%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
SAN DIEGO